Free Trial

CG Oncology (CGON) Institutional Ownership

CG Oncology logo
$30.21 +0.21 (+0.70%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)

Current
Institutional Ownership
Percentage
26.56%
Number of
Institutional Buyers
(last 12 months)
47
Total
Institutional Inflows
(last 12 months)
$848.58M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$100.03M
Get CGON Insider Trade Alerts

Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CGON Institutional Buying and Selling by Quarter

CG Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/26/2024JPMorgan Chase & Co.31,071$1.17M0.0%+59.1%0.041%
11/27/2024Franklin Resources Inc.1,230,193$46.16M0.0%+8.9%1.618%
11/18/2024Neo Ivy Capital Management29,678$1.12M0.4%N/A0.044%
11/16/2024Geode Capital Management LLC1,078,527$40.70M0.0%+96.2%1.608%
11/15/2024M&T Bank Corp16,758$632K0.0%+55.7%0.025%
11/15/2024Barclays PLC90,520$3.42M0.0%+331.1%0.119%
11/15/2024Jane Street Group LLC195,951$7.39M0.0%+240.5%0.292%
11/15/2024Wellington Management Group LLP510,219$19.25M0.0%+153.4%0.761%
11/15/2024State Street Corp1,700,653$64.17M0.0%+73.0%2.535%
11/15/2024Point72 Asset Management L.P.746,063$28.15M0.1%+575.7%1.112%
11/15/2024Polar Asset Management Partners Inc.25,800$973K0.0%N/A0.038%
11/15/2024Janus Henderson Group PLC1,526,534$57.60M0.0%+7.0%2.276%
11/15/2024HighVista Strategies LLC15,734$594K0.2%N/A0.023%
11/15/2024ArrowMark Colorado Holdings LLC230,390$8.69M0.1%+17.4%0.343%
11/14/2024Braidwell LP3,170,875$119.64M3.4%-4.2%4.727%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC21,122$797K0.0%-10.6%0.031%
11/14/2024Ally Bridge Group NY LLC263,266$9.93M5.3%+50.5%0.392%
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank6,399$241K0.0%N/A0.010%
11/14/2024Yu Fan163,456$6.17M19.0%-89.6%0.244%
11/14/2024ABG WTT Global Life Science Capital Partners GP Ltd495,526$18.70M92.9%-45.9%0.739%
11/14/2024MetLife Investment Management LLC27,132$1.02M0.0%+103.2%0.040%
11/13/2024BNP Paribas Financial Markets26,660$1.01M0.0%+876.9%0.040%
11/13/2024FMR LLC145,606$5.49M0.0%+83,581.6%0.217%
11/13/2024The Manufacturers Life Insurance Company73,149$2.76M0.0%+21.3%0.109%
11/12/2024Charles Schwab Investment Management Inc.379,664$14.33M0.0%+114.0%0.566%
11/12/2024Massachusetts Financial Services Co. MA279,945$10.56M0.0%+4.9%0.417%
11/4/2024Los Angeles Capital Management LLC22,052$832K0.0%N/A0.033%
11/4/2024TimesSquare Capital Management LLC437,069$16.49M0.2%+27.4%0.652%
10/30/2024Amalgamated Bank1,621$61K0.0%+107.6%0.002%
10/3/2024 SG Americas Securities LLC17,595$664K0.0%N/A0.026%
9/16/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%
8/19/2024Point72 Asset Management L.P.110,410$3.49M0.0%-40.7%0.166%
8/16/2024Perceptive Advisors LLC733,695$23.16M0.6%-43.7%1.101%
8/16/2024Driehaus Capital Management LLC106,951$3.38M0.0%-0.9%0.160%
8/15/2024Scientech Research LLC8,803$278K0.1%-27.8%0.013%
8/15/2024The Manufacturers Life Insurance Company60,301$1.90M0.0%-5.4%0.090%
8/15/2024Deerfield Management Company L.P. Series C433,540$13.69M0.2%+811.9%0.651%
8/15/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%
8/14/2024Marshall Wace LLP75,982$2.40M0.0%N/A0.114%
8/14/2024Yu Fan1,578,344$49.83M65.1%N/A2.368%
Stunning Trump Manhattan Project Now Underway (Ad)

Just as I predicted, President Trump announced his #1 move during his first 100 days... His allies are calling it Trump’s Manhattan Project.

8/14/2024Ally Bridge Group NY LLC174,876$5.52M3.3%-45.4%0.262%
8/14/2024Profund Advisors LLC9,513$300K0.0%N/A0.014%
8/13/2024Ensign Peak Advisors Inc60,565$1.91M0.0%N/A0.091%
8/9/2024Renaissance Technologies LLC43,200$1.36M0.0%+204.2%0.065%
8/9/2024Massachusetts Financial Services Co. MA266,787$8.42M0.0%+2.7%0.400%
8/3/2024TD Asset Management Inc93,084$2.94M0.0%N/A0.140%
8/1/2024Rhumbline Advisers34,229$1.08M0.0%+13.0%0.051%
7/26/2024Bank of New York Mellon Corp89,344$2.82M0.0%+38.4%0.134%
5/17/2024RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097%
5/16/2024California State Teachers Retirement System2,341$103K0.0%N/A0.004%
5/16/2024Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283%
5/16/2024BVF Inc. IL1,884,191$82.72M2.3%N/A2.827%
5/16/2024Blackstone Inc.25,000$1.10M0.0%N/A0.038%
5/15/2024Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489%
5/15/2024Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050%
5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061%
5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191%
5/14/2024American International Group Inc.306,226$13.44M0.0%N/A0.460%
5/13/2024Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003%
5/10/2024Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339%
5/7/2024TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336%
5/1/2024Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028%
5/1/2024BNP Paribas Financial Markets11,198$492K0.0%N/A0.017%
(Data available from 1/1/2016 forward)

CGON Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CGON shares?

During the previous two years, 54 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Braidwell LP ($119.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), State Street Corp ($64.17M), RA Capital Management L.P. ($61.35M), and Janus Henderson Group PLC ($57.60M).Learn more on CGON's institutional investors.

What percentage of CG Oncology stock is owned by institutional investors?

26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings.

Which institutional investors have been buying CG Oncology stock?

Of the 47 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Janus Henderson Group PLC ($1.62M), Yu Fan ($1.58M), RA Capital Management L.P. ($1.40M), and Price T Rowe Associates Inc. MD ($992.12K).

How much institutional buying is happening at CG Oncology?

Institutional investors have bought a total of 20,439,465 shares in the last 24 months. This purchase volume represents approximately $848.58M in transactions.

Which CG Oncology major shareholders have been selling company stock?

Of the 11 institutional investors that sold CG Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Yu Fan ($1.41M), Perceptive Advisors LLC ($570.41K), ABG WTT Global Life Science Capital Partners GP Ltd ($419.98K), Ally Bridge Group NY LLC ($145.50K), Braidwell LP ($138.63K), Point72 Asset Management L.P. ($75.83K), and Point72 Asia Singapore Pte. Ltd. ($7.45K).

How much institutional selling is happening at CG Oncology?

Institutional investors have sold a total of 2,783,055 shares in the last 24 months. This volume of shares sold represents approximately $100.03M in transactions.



This page (NASDAQ:CGON) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners